ORYZON Strengthens Patent Portfolio for Iadademstat and Vafidemstat with New Decisions to Grant
In Australia and EuropeMADRID and CAMBRIDGE, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY),...
Autism
ORYZON Strengthens Patent Portfolio for Iadademstat and Vafidemstat with New Decisions to Grant
In Australia and EuropeMADRID and CAMBRIDGE, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY),...
Action Behavior Centers Partners with El Paso Chihuahuas for Autism Awareness Night
EL PASO, TX / ACCESS Newswire / September 13, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based...
NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults
BOSTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing treatments for neurological disorders and neuro-oncology,...
Dr. Robert Melillo and ‘A Moment of Xen’ join forces to bring ‘Brain-Based Wellness’ to National Radio, Digital Streaming TV, and social platforms
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- 'A Moment of Xen', the acclaimed Tri-State talk show hosted by celebrated media...
Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases
In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" that drives...
Action Behavior Centers Expands ABC Academy With Eight New Locations to Support School-Age Children with Autism
Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum...
Neo Sophia Launches Free AI Autism Screener Built on AAP-Recommended Guidelines
A clinically validated screening tool, now redesigned for parents with AI support and instant results at home. ATLANTA, Aug. 25, 2025 /PRNewswire/ -- Neo Sophia today announced the launch...
Action Behavior Centers Marks One-Year Anniversary of Action Institute for Outcomes Research
AUSTIN, TX / ACCESS Newswire / August 22, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based applied...
Action Behavior Centers Celebrates August Graduates, Marks 1-Year Anniversary of Action Institute for Outcomes Research
AUSTIN, TX / ACCESS Newswire / August 21, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based applied...
Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan
These recent LungFit PH international agreements bring the ex-U.S. total to 34 countries and a combined population of 2.7 billion...
Center for Social Dynamics Celebrates First Graduating Class of CSD University’s Leadership Academy
Empowering Emerging Leaders Through Research-Backed Training and Measurable Growth CONCORD, Calif., Aug. 19, 2025 /PRNewswire/ -- Center for Social Dynamics...
RethinkFirst Acquires Joshin to Create First Fully Integrated Neurodiversity and Disability Support Platform
Combining intelligent tools and personalized support, RethinkCare empowers employers, families and caregivers with clinically validated resources, expert coaching and navigation...
ATrack Becomes First ABA Software Platform to Offer Vineland-3 Integration via New Pearson Agreement
Collaboration brings the Vineland-3 assessment directly into ATrack's clinical software, bringing greater accuracy and time savings to BCBA treatment planning....
HealthEquity Community Foundation Expands National Impact with $50,000 in Grants
Funding supports 20 nonprofit organizations focused on physical and mental health, financial literacy, and basic needs as the foundation grows...
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes Driving Tumor Growth, Autoimmune Disease, Neurodegeneration, and Metabolic Dysfunction
New data from Eurofins Discovery show that Telomir-1 blocks enzymes that drive disease by turning off critical genes-highlighting its potential...
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency...
Little Leaves Behavioral Services Opens Two New Locations in Maryland
ABA therapy centers in Middle River and Owings Mills expand access to high-quality, early intervention services for young children with...
Little Leaves Behavioral Services Opens Two New Locations in Maryland
ABA therapy centers in Middle River and Owings Mills expand access to high-quality, early intervention services for young children with...
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...